Approval for the bio-rad monolisa anti-hbc eia.  The device is indicated for:  the monolisa anti-hbc eia is an enzyme immunoassay intended for use in the qualitative detection of total antibodies (igg/igm) to hepatitis b core antigen (anti-hbc) in human serum and plasma (potassium edta, sodium citrate, acd (acid citrate dextrose), lithium heparin and sodium heparin).  Assay results may be used with other hbv serological markets for the laboratory diagnosis of hbv disease associated with hbv infection.